133 related articles for article (PubMed ID: 23127262)
1. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
Okuyaz C; Kursel O; Komur M; Tamer L
Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
[TBL] [Abstract][Full Text] [Related]
2. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
[TBL] [Abstract][Full Text] [Related]
3. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
[TBL] [Abstract][Full Text] [Related]
4. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine.
Cansu A; Serdaroglu A; Cinaz P
Eur J Paediatr Neurol; 2011 Nov; 15(6):527-31. PubMed ID: 21703891
[TBL] [Abstract][Full Text] [Related]
6. Effects of topiramate on weight and metabolism in children with epilepsy.
Li HF; Zou Y; Xia ZZ; Gao F; Feng JH; Yang CW
Acta Paediatr; 2009 Sep; 98(9):1521-5. PubMed ID: 19508301
[TBL] [Abstract][Full Text] [Related]
7. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.
Tokgoz H; Aydin K; Oran B; Kiyici A
Childs Nerv Syst; 2012 Jul; 28(7):1049-53. PubMed ID: 22645062
[TBL] [Abstract][Full Text] [Related]
8. Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment.
Genc BO; Dogan EA; Dogan U; Genc E
J Clin Neurosci; 2010 Oct; 17(10):1256-9. PubMed ID: 20598547
[TBL] [Abstract][Full Text] [Related]
9. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children.
Andiran N; Celik N; Ark N; Koca C; Kurtaran H; Karabel D
J Pediatr Endocrinol Metab; 2013; 26(7-8):683-7. PubMed ID: 23612639
[TBL] [Abstract][Full Text] [Related]
10. Predictors of weight loss in adults with topiramate-treated epilepsy.
Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of body weight and serum leptin levels in patients treated with topiramate.
Theisen FM; Beyenburg S; Gebhardt S; Kluge M; Blum WF; Remschmidt H; Elger CE; Hebebrand J
Clin Neuropharmacol; 2008; 31(4):226-30. PubMed ID: 18670246
[TBL] [Abstract][Full Text] [Related]
12. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate.
Cansu A; Serdaroglu A; Camurdan O; Hırfanoğlu T; Cinaz P
Horm Res Paediatr; 2011; 76(1):65-71. PubMed ID: 21659721
[TBL] [Abstract][Full Text] [Related]
14. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study.
Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
Aydin K; Serdaroglu A; Okuyaz C; Bideci A; Gucuyener K
J Child Neurol; 2005 Oct; 20(10):848-51. PubMed ID: 16417885
[TBL] [Abstract][Full Text] [Related]
16. [Changes of body weight and galanin in epileptic children treated with topiramate].
Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J
Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624
[TBL] [Abstract][Full Text] [Related]
17. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.
Kobeissy FH; Jeung JA; Warren MW; Geier JE; Gold MS
Addict Biol; 2008 Mar; 13(1):15-25. PubMed ID: 17910739
[TBL] [Abstract][Full Text] [Related]
18. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects.
Husum H; Van Kammen D; Termeer E; Bolwig G; Mathé A
Neuropsychopharmacology; 2003 Jul; 28(7):1292-9. PubMed ID: 12700690
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between serum ghrelin and lipid profile and serum leptin, adiponectin, and insulin among children in Beijing, China].
Du S; Hu X; Liu A; Zhang Q; Pan H; Ma G
Wei Sheng Yan Jiu; 2013 Mar; 42(2):252-6, 262. PubMed ID: 23654102
[TBL] [Abstract][Full Text] [Related]
20. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
